Abstract
Background Skin involvement is frequent in ALK-positive anaplastic large cell lymphomas. The role of an insect bite as a triggering event has been postulated but not well documented.Design and Methods We retrospectively investigated five cases of ALK-positive anaplastic large cell lymphoma who presented with skin lesions occurring after an insect bite. Biopsies were immunostained with antibodies against CD30, ALK, T- and B-cell antigens.Results Persistent skin lesions developed after solitary insect bites in three patients and after multiple bites in two. Regional lymphadenopathy developed within weeks after the bite in three cases. In four cases the correct diagnosis was delayed due to misinterpretation of the findings as a reactive infiltrate in the skin (n=2) or lymph nodes (n=2); all cases subsequently showed small numbers of cells with nuclear and cytoplasmic staining for ALK. The final diagnoses were lymphohistiocytic variant (n=3) and composite common/small cell type (n=2) anaplastic large cell lymphoma. The patients were treated and three were alive at the last follow-up. Two patients died, one of pneumonia and the other of disseminated disease.Conclusions In these cases the sequence of events between the insect bites and the occurrence of both skin lesions and satellite lymphadenopathy suggest a direct relationship between the bite and the presentation with anaplastic large cell lymphoma. We postulate that insect bite-associated antigens could result in an influx of T lymphocytes, some bearing the t(2;5). The subsequent release of cytokines at the site of the bite could act as a ‘second hit’, eliciting activation of the latter cells, which would then express the oncogenic NPM-ALK protein and undergo uncontrolled proliferation.Introduction
Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is recognized as a distinct entity in the 2008 World Health Organization (WHO) classification of malignant lymphomas.1 The majority of ALCL are associated with a reciprocal translocation, t(2;5)(p23;q35) which juxtaposes the gene at 5q35 encoding nucleophosmin (NPM), a nucleolar-associated phosphoprotein, with the gene coding for a tyrosine kinase receptor, ALK, at 2p23.2 However, variant translocations involving ALK and other partner genes on chromosomes 1, 2, 3, 17, 19 and 22 have been described.3 All result in abnormal expression of ALK chimeric proteins, with tyrosine kinase activity and oncogenic properties.3 ALK fusion proteins can be detected with anti-ALK antibodies, which are of crucial diagnostic value to identify lesions that may resemble ALK-positive ALCL morphologically and phenotypically (i.e. CD30 expression, T/null phenotype), such as ALK-negative ALCL and some primary cutaneous CD30-positive lymphoproliferative disorders (i.e. primary cutaneous ALCL and lymphomatoid papulosis).4–7
ALK-positive ALCL are characterized by frequent extranodal involvement, notably skin involvement (reported in 20–30% of cases), which has a negative prognostic impact.1,8 Given the broad morphological spectrum of ALK-positive ALCL, the diagnosis of ALCL presenting with cutaneous involvement is not always easy, a fact which explains the original histopathological diagnosis of “non-malignant inflammatory disease” in some cases.9 Occasionally, the latter erroneous diagnosis may be suggested by a clinical history of an insect bite.9 Interestingly, the role of an insect bite as an event triggering systemic ALCL has been postulated, although it remains controversial.10 We report here five cases of systemic ALK-positive ALCL presenting at onset with skin lesions occurring after an insect bite.
Design and Methods
Between 1984 and 2007, five children with similar clinical and histological features were identified among a series of more than 400 patients with ALK-positive ALCL from different institutions. The clinicopathological features of one of these cases (n. 4) have already been reported.10 All five children presented with a systemic ALK-positive ALCL occurring after an insect bite. Clinical data, including age at diagnosis, presenting symptoms, clinical stage of disease, treatment, and follow-up, were collected from the patients’ charts. The diagnosis of ALK-positive ALCL was made from a skin biopsy in one case (# 3), both skin and lymph node biopsies in two cases (# 2 and 5) and from a lymph node biopsy in the two remaining cases (# 1 and 4). In case # 1, a lung biopsy was also performed because of pulmonary atelectasis. Hematoxylin and eosin (H&E)- and immunohistochemical-stained slides from archival material were reviewed and additional stains performed when paraffin blocks were available. For case # 5, immunostaining was performed on de-stained H&E sections as previously described.11 Overall, in addition to monoclonal antibodies against CD30/BerH2 and ALK, most cases were immunostained for epithelial membrane antigen (EMA) and several T-cell (CD2, CD3, CD4, CD5, CD7, CD8, CD43) and B-cell markers (CD20, CD79a). Antibody binding was detected with Dako REAL Detection System (Code K5001).
Results
The patients’ clinical features at presentation, diagnosis, treatment and follow-up data are summarized in Table 1. Three patients were male and two female and they ranged in age from 7 to 11 years old. They received solitary (cases # 1, 3, and 4) or multiple insect bites (cases # 2 and 5). Four of them (cases # 1, 2, 3, 5) presented with persistent or growing skin lesions at the site of the bite. Satellite lymphadenopathy developed a few weeks after the bite in two cases (cases # 1 and 2). In one case (# 4), supraclavicular lymphadenopathy, which occurred 1 month after a neck bite, was the presenting symptom. All patients received antibiotics or steroids with no response in four cases (# 1, 2, 3 and 4) and a partial response in one case (case # 5). Four patients had fever at the time of diagnosis and two of the patients’ general condition deteriorated with weight loss, asthenia, and pulmonary signs (cases # 1 and 4). In one case (# 4), the nature of the insect bite was clearly identified as being a tick bite on the neck 1 month earlier with a positive test for Rickettsia. A tick bite was also suspected in case # 1 but no serological testing was performed. In case # 3, the skin lesions appeared, according to the patient’s family, after a wasp bite and in the two remaining cases (# 2 and 5) the nature of the insect bites remained undetermined. However, the clinical history of case # 5 left no doubt regarding the crucial role of insect bites in the presentation of the disease. Briefly, this 9-year old white male went on a camping trip in May 1984 with his boy scout troop. He received multiple insect bites. Most of these resolved but 2–3 weeks later he developed new lesions, up to the size of 2 cm, on his back and neck. After a course of steroids, all the lesions resolved except one on the left flank. The lesion was biopsied and a diagnosis of “non-specific reactive infiltrate” was originally made (Figure 1A). After the first biopsy, the lesion did not heal and progressively enlarged. A new skin biopsy was performed in February 1985 and led to the diagnosis of “large cell immunoblastic lymphoma”. Approximately 1 week later the patient underwent surgical resection of a left axillary lymph node which enabled the diagnosis of lymphoma to be confirmed (Figure 1C–D).
Except for case n. 4, previously reported,10 all the other cases were observed before the availability of anti-ALK antibodies and only CD30 and EMA stains were initially performed.4,5 All skin and lymph node biopsies were reexamined. In addition to CD30 and EMA, ALK staining and several T- and B-cell markers were used. In case n. 1, the lymph node lesion originally interpreted as lymphadenitis rich in macrophages proved to be an ALK-positive lymphohistiocytic ALCL (Figure 2A). Scattered CD30 and EMA-positive cells were also positive for ALK protein (Figure 2B). Some large atypical cells with “hallmark cell” features were associated with a small cell component showing nuclear-restricted ALK staining. A few months later, the patient developed pulmonary symptoms with cough and atelectasis secondary to a bronchial tumor diagnosed as “Ki-1 lymphoma” (i.e. CD30). This lesion consisted of a pure population of large basophilic cells (i.e. hallmark cells) that met the criteria of ALK-positive common type ALCL. Comparable features were observed in the supraclavicular lymph node biopsy from case n. 4 in whom lymphadenopathy appeared after a tick bite on the neck 1 month earlier (Figure 2C). The diagnosis of “hyper-immune reaction” was made initially, but despite steroids and antibiotics, the patient’s general condition deteriorated rapidly in association with liver and spleen enlargement. Chest X-rays showed a mediastinal mass with pulmonary failure.10 Finally, the diagnosis was revised to ALK-positive lymphohistiocytic ALCL (Figure 2D). A small cell component was also noted in this case after ALK staining (Figure 2D).
All patients presented with skin lesions that were clinically related to insect bites and were biopsied in three instances (# 2, 3 and 5). In one case (# 3) a skin biopsy of a tumor that developed at the site of a wasp bite led to the accurate diagnosis of “Ki-1 lymphoma” based on morphological features and reactivity of neoplastic cells with antibodies against CD30, EMA and CD3. ALK staining revealed areas consisting of large cells associated with a dominant population of small- to medium-sized cells suggesting an ALK-positive ALCL with a “composite pattern” (Figure 3 A–B). Case # 2 received insect bites of unknown nature on the wrist in March 1986. A skin biopsy was performed and a conventional examination revealed a dense lymphoid infiltrate rich in histiocytes (Figure 3C) initially considered to be a “non-specific reactive infiltrate”. The patient was treated with antibiotics but the skin lesion persisted and 3 months later, she developed axillary lymphadenopathy that was resected. Immunostaining of the skin biopsy showed scattered medium- to large-sized cells, highlighted by CD30 and ALK stains, on a lymphohistiocytic background (Figure 3D). The lymph node was massively involved by an ALK-positive ALCL, lymphohistiocytic pattern. In case # 5, the first skin biopsy was also interpreted as a “reactive infiltrate” possibly related to insect bite. Given that no paraffin block was available, the H&E-stained section was used to perform ALK staining and revealed scattered, strongly positive cells of small to medium size on a dominant background of negative lymphoid cells admixed with histiocytes and plasma cells (Figure 1B). A second skin biopsy at the same site and surgical resection of enlarged axillary lymph node was performed 10 months later. Both were massively involved by a monomorphic infiltrate of large cells, many with “hallmark cell” features, strongly positive for ALK protein. A minor population of ALK-positive small cells was also observed suggesting an ALCL with a “common pattern” associated with a minor small cell component. Overall, the final diagnosis in these five cases was ALK-positive ALCL, with a “lymphohistiocytic pattern” in three cases (# 1, 2, and 4) and a “composite pattern” (common plus small cell pattern) in the other two cases (# 3 and 5). In all cases neoplastic cells were strongly positive for ALK and the staining pattern (i.e. cytoplasmic, nuclear and nucleolar staining) was highly indicative of NPM-ALK fusion protein and the associated t(2;5) translocation.
All patients were eventually treated with multi-agent chemotherapy, associated with radiotherapy and autologous bone marrow transplant in one case (# 1). Three patients (cases # 1, 4, 5) achieved a complete remission and were alive without any evidence of disease at the last follow-up. Two patients died, one of a Cytomegalovirus-associated pneumonia during an aplastic phase following treatment (case # 2) and the other (case # 3) of disseminated disease 19 months after diagnosis.
Discussion
The cases reported here raise the question of whether the insect bites were coincidental or played a role in the development of these ALCL. Although we cannot exclude a coincidental association, the clinical context and the sequence of events between the insect bites, and the occurrence of both skin lesions and lymphadenopathy in the corresponding anatomical areas suggest a direct relationship. In addition to a report by Piccaluga et al.,10 similar cases can be found in the literature even though the authors did not stress the potential role of insect bites in the clinical presentation or evolution of ALCL. Four of the six cases described by Kadin et al.9 had a clinical diagnosis of insect bite and in two cases the initial differential diagnoses of pathologists included “non-malignant inflammatory disease”. It is not, however, clear from their report whether the ALCL skin lesions followed or had been mistaken for arthropod bites.9 Nevertheless, as in our cases, this study underscores the fact that some skin involvement in ALK-positive ALCL may closely resemble non-specific inflammatory infiltrate, as in cases # 2 and 5 of the present study, and that an accurate diagnosis cannot be made without ALK staining which may reveal scarce positive neoplastic cells. ALK staining may also be of crucial diagnostic value in the recognition of some variants of ALCL involving lymph nodes, particularly the lymphohistiocytic subtype.12 It is noteworthy that the latter ALCL pattern, which is relatively rare (<10% of ALCL), was observed in three (# 1, 2, and 4) of the five cases. All these diagnostic uncertainties were responsible for the correct treatment being delayed for weeks to months.
Two other reports mention an insect bite in the clinical history of patients with ALCL. In 2000, Gould et al.13 reported the case of a 4-year old girl presenting with a primary cutaneous ALK-positive ALCL that first appeared 6 months earlier coincidental to multiple urticarial arthropod bite reactions. Although, clinical details are missing, this case has some similarities with case n. 5 of the present study. The evolution was, however, different from the latter case since surgical resection was performed, no extra-cutaneous disease was found and the patient has been free of disease for more than 44 months since the surgical resection. The final diagnosis was solitary primary cutaneous ALK-positive ALCL. The other case was reported in 2007 by Rannan-Eliya et al.14 A 14-year old female received an insect bite near her umbilicus. Six months later she presented with a fluctuant lesion in the same region and excision and drainage revealed granulation tissue without apparent evidence of malignancy. Subsequent biopsy of persistent skin induration revealed an ALK-positive ALCL with further dissemination and fatal relapse in the central nervous system.
In all these cases the nature of the arthropod bite was not clearly demonstrated except for the patient reported by Piccaluga et al.10 who received a tick bite 20 days prior to the diagnosis of ALK-positive systemic ALCL. Serological tests revealed weak positivity for anti-rickettsial antibodies. A tick bite was also suspected in case # 1 of the present study, who developed a persistent skin lesion and lymphadenopathy, but no serological tests were performed. In the literature and in our cases the time elapsed between the insect bite and the diagnosis of ALCL varied from a few weeks to 6 months.
Ticks carry many pathogens, the most common being Borrelia burgdorferi, the spirochete responsible for Lyme disease which has been implicated in the pathogenesis of at least a subset of cutaneous marginal-zone B-cell lymphomas15–17 and one case of angioimmunoblastic T-cell lymphoma.18 Several reports have been published on the puzzling relationship between insect bites and lymphoma. In 1965, Weed et al. described the occurrence of unusual cutaneous lesions secondary to insect bites in certain patients with chronic lymphocytic leukemia.19 These lesions were attributed to an exaggerated immune response to mosquito antigens, perhaps due to a greater local mobilization of lymphocytes in these patients. This same phenomenon was subsequently reported not only in patients with chronic lymphocytic leukemia, but also in patients with other lymphoproliferative diseases.20 However, as only few patients recalled arthropod assaults, the role of insect bites in the initiation of such eruptions has remained controversial and the term “insect bite-like reaction” has been proposed.20
Another example of the role of insect bites in lymphoproliferative disorders is the syndrome of hypersensitivity to insect bites associated with chronic active Epstein-Barr virus infection.21–23 In this syndrome, CD4 T cells stimulated by mosquito antigens may reactivate latent Epstein-Barr virus infection in NK/T cells and contribute to their unregulated expansion within inflammatory skin lesions and in the peripheral circulation.24–28 A significant proportion of these patients die of Epstein-Barr virus-positive NK/T-cell lymphoma or hemophagocytic syndrome.21–23,29 A comparable scenario can be proposed regarding the possible role of insect bites as a triggering factor in the presentation of ALCL. Insect bite-associated antigens could result in an influx of CD4 T lymphocytes, some of them bearing the t(2;5) translocation. The presence of the NPM-ALK fusion transcript has been detected by real-time reverse transcriptase polymerase chain reaction analysis in reactive lymph nodes30 and normal peripheral blood samples of healthy individuals.31 The subsequent release of cytokines at the site of an insect bite could act as a ‘second hit’, eliciting the activation and proliferation of the latter cells, which would then express the oncogenic NPM-ALK fusion protein and undergo uncontrolled proliferation. Alternatively, children might have occult disease at the time of the bite, with the release of cytokines precipitating an influx of neoplastic cells to the site of inflammation via chemotaxis.
Acknowledgments
The authors thank Dr Darasse, Dr Carre, Pr Floquet, Dr Aymard, Dr Schmitt, and Dr Johal for providing histological material and clinical data. We also thank Michel March for technical assistance.
Footnotes
- Authorship and Disclosures GD, SP, and EJ recruited the patients. LL, GD and EJ wrote the paper.
- The authors reported no potential conflicts of interest.
- Funding: this work was partly supported by A.I.R.C. (Milan), by the intramural research program of the Center for Cancer Research, National Cancer Institute and by the Programme d’Action Intégrée de Recherche sur les Lymphomes, Institut National du Cancer (PAIR lymphomes).
- Received August 24, 2009.
- Accepted September 14, 2009.
References
- World Health Organization (WHO) classification of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon; 2008. Google Scholar
- Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science. 1994; 263(5151):1281-4. PubMedhttps://doi.org/10.1126/science.8122112Google Scholar
- Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer. 2008; 8(1):11-23. PubMedhttps://doi.org/10.1038/nrc2291Google Scholar
- Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997; 89(4):1394-404. PubMedGoogle Scholar
- Falini B, Bigerna B, Fizzoti M, Pulford K, Pileri S, Delsol G. ALK expression defines a distinct group of T/null lymphomas (“ALK lymphomas”) with a wide morphological spectrum. Am J Pathol. 1998; 153(3):875-86. PubMedhttps://doi.org/10.1016/S0002-9440(10)65629-5Google Scholar
- World Health Organization (WHO) classification of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon; 2008. Google Scholar
- World Health Organization (WHO) classification of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon; 2008. Google Scholar
- Le Deley MC, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K. European Intergroup for Childhood Non-Hodgkin Lymphoma. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood. 2008; 111(3):1560-6. PubMedhttps://doi.org/10.1182/blood-2007-07-100958Google Scholar
- Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986; 68(5):1042-9. PubMedGoogle Scholar
- Piccaluga PP, Ascani S, Fraternali Orcioni G, Piccioli M, Pileri A. Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. Haematologica. 2000; 85(9):978-81. PubMedGoogle Scholar
- Voigt JJ, Al Saati T, Caveriviere P, Faure P, Gorguet B, Delsol G. Value of immunoperoxidase with monoclonal antibodies after dismounting of previously stained sections. Ann Pathol. 1986; 6(4–5):345-7. PubMedGoogle Scholar
- Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugières L, Terrier-Lacombe MJ. ALK-positive lymphoma; a single disease with a broad spectrum of morphology. Blood. 1998; 91(6):2076-84. PubMedGoogle Scholar
- Gould JW, Eppes RB, Gilliam AC, Goldstein JA, Mikkola DL, Zaim MT, Wood GS. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype antibody ALK1 bearing the t(2;5)(p23;q35) translocation and presenting in a child. Am J Dermatopathol. 2000; 22(5):422-8. PubMedGoogle Scholar
- Rannan-Eliya YF, Pulford K, Johnson R, Peart I, Kokai G, Baillie C. Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration. Pediatr Blood Cancer. 2008; 50(4):879-81. PubMedhttps://doi.org/10.1002/pbc.21357Google Scholar
- Cerroni L, Zöchling N, Pütz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997; 24(8):457-61. PubMedhttps://doi.org/10.1111/j.1600-0560.1997.tb01318.xGoogle Scholar
- Goodlad J, Davidson M, Hollowood K, Batstone P, Ho-Yen D. Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi associated cell proliferation in the skin. Histopathology. 2000; 37(6):501-8. PubMedhttps://doi.org/10.1046/j.1365-2559.2000.01003.xGoogle Scholar
- Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol. 2000; 31(2):263-8. PubMedhttps://doi.org/10.1016/S0046-8177(00)80233-6Google Scholar
- Hatanaka K, Miyagishima T, Kamata T, Nakagawa M, Miura Y, Arai S. Occurrence of angioimmunoblastic T-cell lymphoma six months after onset of Lyme disease. Rinsho Ketsueki. 2000; 41(12):1273-6. PubMedGoogle Scholar
- Weed RI. Exaggerated delayed hypersensitivity to mosquito bites in chronic lymphocytic leukemia. Blood. 1965; 26:257-68. PubMedGoogle Scholar
- Barzilai A, Shpiro D, Goldberg I, Yacob-Hirsch Y, Diaz-Cascajo C, Meytes D. Insect bite–like reaction in patients with hematologic malignant neoplasms. Arch Dermatol. 1999; 135(12):1503-7. PubMedhttps://doi.org/10.1001/archderm.135.12.1503Google Scholar
- Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol. 1997; 133(9):1081-6. PubMedhttps://doi.org/10.1001/archderm.1997.03890450023003Google Scholar
- Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol. 2006; 142(5):587-95. PubMedhttps://doi.org/10.1001/archderm.142.5.587Google Scholar
- World Health Organization (WHO) classification of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon; 2008. Google Scholar
- Ishihara S, Ohshima K, Tokura Y, Yabuta R, Imaishi H, Wakiguchi H. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res. 1997; 88(1):82-7. https://doi.org/10.1111/j.1349-7006.1997.tb00305.xGoogle Scholar
- Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus–associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol. 2001; 45(4):569-78. PubMedhttps://doi.org/10.1067/mjd.2001.114751Google Scholar
- Asada H, Miyagawa S, Sumikawa Y, Yamaguchi Y, Itami S, Suguri S. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Arch Dermatol. 2003; 139(12):1601-7. PubMedhttps://doi.org/10.1001/archderm.139.12.1601Google Scholar
- Kanno H, Onodera H, Endo M, Maeda F, Chida S, Akasaka T, Sawai T. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction. Hum Pathol. 2005; 36(2):212-8. PubMedhttps://doi.org/10.1016/j.humpath.2004.11.005Google Scholar
- Asada H. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci. 2007; 45(3):153-60. PubMedhttps://doi.org/10.1016/j.jdermsci.2006.11.002Google Scholar
- Mizuki M, Ueda S, Tagawa S, Shibayama H, Nishimori Y, Shibano M. Natural killer cell–derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol. 1998; 59(4):309-15. PubMedhttps://doi.org/10.1002/(SICI)1096-8652(199812)59:4<309::AID-AJH7>3.0.CO;2-BGoogle Scholar
- Maes B, Vanhentenrijk V, Wlodarska I, Cools J, Peeters B, Marynen P, de Wolf-Peeters C. The NPM-ALK and the ATIC-ALK fusion genes can be detected in nonneoplastic cells. Am J Pathol. 2001; 158(6):2185-93. PubMedhttps://doi.org/10.1016/S0002-9440(10)64690-1Google Scholar
- Trumper L, Pfreundschuh M, Bonin FV, Daus H. Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br J Haematol. 1998; 103(4):1138-44. PubMedhttps://doi.org/10.1046/j.1365-2141.1998.01097.xGoogle Scholar